POSSIBILITIES TO USE L-ORNITINE-L-ASPARTATE IN THERAPY OF NON-ALCOHOL FATTY LIVER DISEASE PATIENTS

Today, NAFLD is one of the most common pathologies in the structure of liver diseases. Because the liver itself is involved in many pathological processes, its dysfunction contributes to the development of serious metabolic disorders, detoxification and antimicrobial defense of the body. One of the...

Full description

Saved in:
Bibliographic Details
Published inMedical Council no. 15; pp. 98 - 102
Main Authors Teterina, L. A., Tsurcumia, D. B., Seliverstov, P. V., Sitkin, S. I., Oreshko, L. S., Radchenko, V. G.
Format Journal Article
LanguageEnglish
Russian
Published Remedium Group LLC 01.11.2017
Subjects
encephalopathy
l-ornithine-l-aspartate
liver
nafld
Online AccessGet full text

Cover

More Information
Summary:Today, NAFLD is one of the most common pathologies in the structure of liver diseases. Because the liver itself is involved in many pathological processes, its dysfunction contributes to the development of serious metabolic disorders, detoxification and antimicrobial defense of the body. One of the most frequent complications of liver disease is hepatic encephalopathy, which in most cases is latent.
ISSN:2079-701X
2658-5790
DOI:10.21518/2079-701X-2017-15-98-102